Nalls Sherbakoff Group’s Astera Labs ALAB Stock Holding History

Nalls Sherbakoff Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-250	Closed	-$22.6K	–	438
2025 Q2	$22.6K	Buy	+250	New	+$19.8K	0.02%	265

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Nalls Sherbakoff Group's ALAB Position: Q3 2025 in Review

Nalls Sherbakoff Group sold out of Astera Labs (ALAB) in Q3 2025, closing a stake of 250 shares — an estimated $22.6K sold.

Nalls Sherbakoff Group first reported a position in ALAB in Q2 2025 and held it in 1 quarter. The position peaked at $22.6K in Q2 2025. 659 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

Nalls Sherbakoff Group reported no remaining Astera Labs position as of Q3 2025 after selling out during the quarter.
Nalls Sherbakoff Group sold 250 Astera Labs shares in Q3 2025, an estimated $22.6K.
Nalls Sherbakoff Group first reported a position in Astera Labs in Q2 2025 and held it in 1 quarter.
Nalls Sherbakoff Group's Astera Labs position peaked at $22.6K in Q2 2025.
659 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q3 2025, filed 12 Mar 2026.